These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22362168)

  • 1. Bi-RADS category 3 nonpalpable breast masses on sonography: long-term results of a prospective cohort study.
    Alimoglu E; Alimoglu MK; Ceken K; Kabaalioglu A; Apaydin A; Cassano E; Sindel T
    J Clin Ultrasound; 2012; 40(3):125-34. PubMed ID: 22362168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
    Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
    Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of shear-wave elastography for evaluation of breast masses detected with screening US imaging.
    Lee SH; Chang JM; Kim WH; Bae MS; Seo M; Koo HR; Chu AJ; Gweon HM; Cho N; Moon WK
    Radiology; 2014 Oct; 273(1):61-9. PubMed ID: 24955927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
    Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
    AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
    Neuschler EI; Butler R; Young CA; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Donlan P; Grobmyer SR; Katzen J; Kist KA; Lavin PT; Makariou EV; Parris TM; Schilling KJ; Tucker FL; Dogan BE
    Radiology; 2018 May; 287(2):398-412. PubMed ID: 29178816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
    Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
    Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
    Satake H; Nishio A; Ikeda M; Ishigaki S; Shimamoto K; Hirano M; Naganawa S
    AJR Am J Roentgenol; 2011 Jan; 196(1):202-9. PubMed ID: 21178068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up versus tissue diagnosis in BI-RADS category 3 solid breast lesions at US: a cost-consequence analysis.
    Alimoğlu E; Bayraktar ŞD; Bozkurt S; Çeken K; Kabaalioğlu A; Apaydın A; Sindel HT
    Diagn Interv Radiol; 2012; 18(1):3-10. PubMed ID: 21997885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging.
    Menezes GLG; Pijnappel RM; Meeuwis C; Bisschops R; Veltman J; Lavin PT; van de Vijver MJ; Mann RM
    Radiology; 2018 Aug; 288(2):355-365. PubMed ID: 29664342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
    Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
    Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downgrading and Upgrading Gray-Scale Ultrasound BI-RADS Categories of Benign and Malignant Masses With Optoacoustics: A Pilot Study.
    Neuschler EI; Lavin PT; Tucker FL; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Dogan BE; Grobmyer SR; Katzen J; Kist KA; Makariou EV; Parris TM; Young CA; Butler R
    AJR Am J Roentgenol; 2018 Sep; 211(3):689-700. PubMed ID: 29975115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
    Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
    Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses.
    Berg WA; Cosgrove DO; Doré CJ; Schäfer FK; Svensson WE; Hooley RJ; Ohlinger R; Mendelson EB; Balu-Maestro C; Locatelli M; Tourasse C; Cavanaugh BC; Juhan V; Stavros AT; Tardivon A; Gay J; Henry JP; Cohen-Bacrie C;
    Radiology; 2012 Feb; 262(2):435-49. PubMed ID: 22282182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography.
    Taskin F; Koseoglu K; Ozbas S; Erkus M; Karaman C
    J Clin Ultrasound; 2012 Jun; 40(5):261-5. PubMed ID: 22508447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does power Doppler ultrasonography improve the BI-RADS category assessment and diagnostic accuracy of solid breast lesions?
    Tozaki M; Fukuma E
    Acta Radiol; 2011 Sep; 52(7):706-10. PubMed ID: 21596798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.